 Setareh Salehi Omran
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 27 | 2026 | 1256 | 3.670 |
Why?
| | Vertebral Artery Dissection | 11 | 2026 | 30 | 3.400 |
Why?
| | Carotid Artery, Internal, Dissection | 8 | 2026 | 13 | 2.570 |
Why?
| | Brain Ischemia | 5 | 2026 | 358 | 1.190 |
Why?
| | Endocarditis | 2 | 2019 | 39 | 1.130 |
Why?
| | Diagnostic Errors | 3 | 2026 | 175 | 1.120 |
Why?
| | Anticoagulants | 8 | 2025 | 722 | 1.110 |
Why?
| | Neurology | 2 | 2024 | 112 | 0.920 |
Why?
| | Fibrinolytic Agents | 3 | 2024 | 291 | 0.750 |
Why?
| | Cerebral Arteries | 1 | 2022 | 58 | 0.710 |
Why?
| | Thrombophilia | 1 | 2021 | 88 | 0.650 |
Why?
| | Neurologists | 1 | 2020 | 22 | 0.650 |
Why?
| | Diagnostic Tests, Routine | 1 | 2021 | 108 | 0.620 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2020 | 67 | 0.610 |
Why?
| | Intracranial Hemorrhages | 2 | 2024 | 100 | 0.580 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 3 | 2023 | 10 | 0.580 |
Why?
| | Thrombectomy | 2 | 2022 | 78 | 0.580 |
Why?
| | Cerebral Angiography | 1 | 2018 | 119 | 0.550 |
Why?
| | Atrial Fibrillation | 2 | 2024 | 550 | 0.550 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2025 | 497 | 0.520 |
Why?
| | Computed Tomography Angiography | 1 | 2018 | 145 | 0.510 |
Why?
| | Ischemic Attack, Transient | 3 | 2023 | 71 | 0.500 |
Why?
| | Magnetic Resonance Angiography | 1 | 2018 | 251 | 0.480 |
Why?
| | Cerebrovascular Circulation | 1 | 2018 | 280 | 0.470 |
Why?
| | Thrombolytic Therapy | 3 | 2024 | 163 | 0.450 |
Why?
| | Pregnancy Complications | 1 | 2020 | 592 | 0.430 |
Why?
| | Risk Factors | 16 | 2026 | 10779 | 0.390 |
Why?
| | Internship and Residency | 1 | 2023 | 1257 | 0.380 |
Why?
| | Hospitalization | 3 | 2020 | 2433 | 0.370 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1356 | 0.340 |
Why?
| | Brain | 2 | 2023 | 2933 | 0.320 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 600 | 0.320 |
Why?
| | Humans | 38 | 2026 | 144759 | 0.320 |
Why?
| | Venous Thrombosis | 2 | 2022 | 194 | 0.310 |
Why?
| | Retrospective Studies | 20 | 2026 | 17066 | 0.300 |
Why?
| | Predictive Value of Tests | 3 | 2026 | 2115 | 0.290 |
Why?
| | Middle Aged | 20 | 2026 | 35875 | 0.290 |
Why?
| | Endovascular Procedures | 2 | 2024 | 384 | 0.280 |
Why?
| | Intracranial Embolism | 2 | 2019 | 34 | 0.280 |
Why?
| | Adult | 18 | 2026 | 40449 | 0.280 |
Why?
| | Smoking Cessation | 2 | 2023 | 439 | 0.260 |
Why?
| | Arteries | 3 | 2024 | 259 | 0.260 |
Why?
| | Female | 26 | 2026 | 78271 | 0.260 |
Why?
| | Odds Ratio | 3 | 2026 | 1075 | 0.260 |
Why?
| | Young Adult | 7 | 2024 | 14105 | 0.240 |
Why?
| | Fibromuscular Dysplasia | 1 | 2025 | 8 | 0.230 |
Why?
| | Age Factors | 2 | 2026 | 3333 | 0.230 |
Why?
| | Treatment Outcome | 9 | 2025 | 11679 | 0.220 |
Why?
| | Smoking | 3 | 2023 | 1472 | 0.220 |
Why?
| | Logistic Models | 3 | 2026 | 2117 | 0.210 |
Why?
| | Aged, 80 and over | 8 | 2023 | 8265 | 0.210 |
Why?
| | Aged | 15 | 2026 | 25913 | 0.210 |
Why?
| | Multivariate Analysis | 2 | 2026 | 1539 | 0.210 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2024 | 83 | 0.210 |
Why?
| | Vasospasm, Intracranial | 1 | 2023 | 19 | 0.200 |
Why?
| | Male | 20 | 2026 | 72315 | 0.200 |
Why?
| | Noma | 1 | 2023 | 2 | 0.200 |
Why?
| | Renal Colic | 1 | 2022 | 4 | 0.190 |
Why?
| | Cerebrovascular Disorders | 1 | 2023 | 103 | 0.190 |
Why?
| | Cerebral Veins | 1 | 2022 | 16 | 0.190 |
Why?
| | Status Epilepticus | 1 | 2023 | 56 | 0.180 |
Why?
| | Intracranial Thrombosis | 1 | 2022 | 19 | 0.180 |
Why?
| | Dabigatran | 1 | 2022 | 29 | 0.180 |
Why?
| | Recurrence | 4 | 2026 | 1135 | 0.180 |
Why?
| | Administration, Oral | 2 | 2022 | 847 | 0.170 |
Why?
| | Warfarin | 1 | 2022 | 170 | 0.160 |
Why?
| | Registries | 5 | 2026 | 2385 | 0.160 |
Why?
| | Education, Medical | 1 | 2024 | 274 | 0.160 |
Why?
| | Tissue Plasminogen Activator | 2 | 2024 | 244 | 0.160 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2020 | 16 | 0.160 |
Why?
| | Drug Substitution | 1 | 2020 | 63 | 0.160 |
Why?
| | United States | 7 | 2024 | 15966 | 0.160 |
Why?
| | Mobile Health Units | 1 | 2019 | 20 | 0.150 |
Why?
| | Drug Utilization | 1 | 2020 | 166 | 0.150 |
Why?
| | Fellowships and Scholarships | 1 | 2023 | 357 | 0.150 |
Why?
| | Ambulances | 1 | 2019 | 53 | 0.150 |
Why?
| | Pregnancy | 3 | 2024 | 7190 | 0.150 |
Why?
| | Health Care Surveys | 1 | 2020 | 539 | 0.140 |
Why?
| | Thrombosis | 1 | 2022 | 393 | 0.140 |
Why?
| | Geography | 1 | 2019 | 203 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 634 | 0.140 |
Why?
| | Troponin | 1 | 2017 | 49 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2019 | 243 | 0.130 |
Why?
| | Health Surveys | 1 | 2019 | 518 | 0.130 |
Why?
| | Incidence | 2 | 2024 | 2879 | 0.120 |
Why?
| | Survivors | 1 | 2020 | 520 | 0.120 |
Why?
| | Sex Factors | 2 | 2020 | 2112 | 0.120 |
Why?
| | Medication Adherence | 1 | 2020 | 539 | 0.120 |
Why?
| | Stroke Volume | 1 | 2019 | 651 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 392 | 0.120 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 541 | 0.110 |
Why?
| | Adolescent | 3 | 2020 | 22428 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2020 | 3604 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2310 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1209 | 0.090 |
Why?
| | Administration, Intravenous | 2 | 2024 | 170 | 0.080 |
Why?
| | Depression | 1 | 2020 | 1558 | 0.080 |
Why?
| | Inpatients | 2 | 2024 | 545 | 0.080 |
Why?
| | New York City | 2 | 2019 | 89 | 0.080 |
Why?
| | Risk Assessment | 3 | 2024 | 3671 | 0.070 |
Why?
| | Databases, Factual | 2 | 2024 | 1486 | 0.070 |
Why?
| | Seizures | 2 | 2023 | 460 | 0.070 |
Why?
| | Cohort Studies | 3 | 2025 | 5960 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1720 | 0.050 |
Why?
| | Medicare | 2 | 2020 | 886 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2024 | 95 | 0.050 |
Why?
| | Time Factors | 2 | 2024 | 7173 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2023 | 56 | 0.050 |
Why?
| | Vasoconstriction | 1 | 2023 | 217 | 0.050 |
Why?
| | American Heart Association | 1 | 2024 | 350 | 0.050 |
Why?
| | Child | 1 | 2020 | 22633 | 0.040 |
Why?
| | Varenicline | 1 | 2020 | 28 | 0.040 |
Why?
| | Bupropion | 1 | 2020 | 46 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2024 | 1030 | 0.040 |
Why?
| | Comorbidity | 1 | 2024 | 1658 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2020 | 129 | 0.040 |
Why?
| | Urban Health | 1 | 2019 | 96 | 0.040 |
Why?
| | Prospective Studies | 2 | 2024 | 7990 | 0.040 |
Why?
| | Prevalence | 1 | 2026 | 2834 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2020 | 282 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 809 | 0.040 |
Why?
| | Patient Discharge | 1 | 2024 | 983 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5868 | 0.030 |
Why?
| | Communication | 1 | 2024 | 965 | 0.030 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 120 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2017 | 529 | 0.030 |
Why?
| | Up-Regulation | 1 | 2017 | 851 | 0.030 |
Why?
| | Patient Safety | 1 | 2017 | 347 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2022 | 5408 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 4271 | 0.010 |
Why?
|
|
Salehi Omran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|